5-MAPB is primarily studied for its entactogenic and serotonergic properties within the field of neuropharmacology and chemical neuroscience. As a benzofuran-class compound, it shares structural similarities with MDMA and other monoamine-releasing agents, making it a subject of interest for scientists investigating emotional modulation, receptor activity, and structure–activity relationships (SAR). Its controlled intensity and distinct binding profile provide valuable insight for modeling empathy-inducing compounds without the overstimulation often associated with stronger analogs.

• Receptor Binding Analysis: Researchers study 5-MAPB to determine its interaction with serotonin transporters (SERT), as well as secondary binding to dopamine (DAT) and norepinephrine (NET) transporters. This helps evaluate its reuptake inhibition and releasing properties.

• Entactogenic Effect Modeling: Its ability to induce mild empathogenic responses in receptor simulations makes it useful for entactogen modeling in pharmacological research. It helps define how molecular changes impact emotional connectivity.

• Comparative Pharmacology: 5-MAPB is frequently compared to MDMA, 6-APB, and MDA to assess potency, receptor selectivity, and toxicity profiles. These studies help map the pharmacological spectrum of benzofuran analogs.

• Neurotoxicity Screening: Researchers utilize 5-MAPB to test potential serotonergic neurotoxicity, identifying safer alternatives to more toxic empathogens. Early data suggests it may have a reduced neurotoxic impact relative to MDMA.

• SAR Studies: It plays a critical role in structure-activity relationship experiments, helping researchers understand how substitutions on the benzofuran ring affect psychoactive and pharmacological behavior.

• Binding Affinity Profiling: Scientists assess its Ki values (inhibition constants) for SERT, DAT, and NET receptors to determine its affinity and efficacy in modulating monoamine neurotransmission.

• Dose-Response Testing: Controlled lab testing of dose-dependent responses enables researchers to map its functional thresholds and receptor activation limits.

The legal status of 5-MAPB varies globally and is largely dependent on national laws concerning psychoactive substances and analog legislation. Although it is unscheduled in many jurisdictions, researchers must perform due diligence before purchase, as local laws may classify it under analogue control or blanket psychoactive substance bans.

• Unscheduled in Many Countries: In several regions, 5-MAPB is not listed as a controlled substance, allowing it to be legally purchased for research use.

• Analogue Act Enforcement: In countries like the United States, 5-MAPB could be considered an analogue of MDMA or MDA, placing it under possible prosecution if intended for human consumption.

• Strictly Research-Only Use: Even in legal territories, its use must be limited to laboratory environments. Purchasing with the intent to ingest is illegal and unethical.

• Local Law Variation: Regulations differ dramatically between jurisdictions. For example, the UK may classify it under its Psychoactive Substances Act, whereas other EU countries may not explicitly list it.

• No Prescription Needed for Research: RC Plug does not require a prescription, as we supply 5-MAPB strictly for scientific purposes to researchers and institutions.

• Responsibility on Buyer: It is solely the buyer’s responsibility to verify the legality of receiving and possessing 5-MAPB in their location.

• Customs Risks: If ordered into a restricted country, the package may be confiscated by customs, although we do offer support in such scenarios through documentation or replacements.

The physical characteristics of 5-MAPB typically appear as a white or off-white crystalline powder. Its visual properties are consistent with most high-purity research chemicals, and any significant deviation in color, texture, or consistency may indicate contamination or improper storage. Researchers should always inspect appearance as part of quality assurance before initiating experiments.

• Color: It typically appears as a white to off-white crystalline substance, indicating a high level of refinement and absence of colored impurities.

• Texture: Fine, powder-like, and non-clumpy in its pure form. Proper crystallization prevents agglomeration and allows easier measurement for analytical use.

• Solubility Check: It dissolves cleanly in ethanol and DMSO, forming clear solutions. Undissolved particles may indicate impurities or moisture exposure.

• Moisture Sensitivity: Exposure to humid environments can alter the texture, making the powder clumpy or sticky—this is why sealed storage is crucial.

• Consistency Across Batches: Legitimate suppliers like RC Plug ensure that every batch is visually identical, ensuring reproducibility in research settings.

• No Foul Odor: There should be no strong chemical odor; any unusual smell may suggest degradation or contamination from improper synthesis or handling.

5-MAPB is a synthetic compound with a benzofuran backbone and a methylaminopropyl side chain. This structure aligns it closely with MDMA and other entactogens but features distinct ring substitutions that modify its pharmacological behavior. Understanding the chemical layout is critical for receptor modeling and computational docking studies.

• Benzofuran Ring System: The defining feature of 5-MAPB is its fused benzofuran moiety—a benzene ring fused with a furan ring—which differentiates it from typical phenethylamines.

• Side Chain Substitution: It has a 2-methylaminopropyl side chain at the 5-position of the benzofuran, responsible for its serotonin transporter activity.

• Molecular Formula: C11H15NO — composed of carbon, hydrogen, nitrogen, and oxygen atoms, consistent with entactogen analogues.

• Molecular Weight: 177.24 g/mol — this weight is used in solution preparation and calibration for dosage measurements in research.

• IUPAC Name: 1-(benzofuran-5-yl)-N-methylpropan-2-amine — the name reflects the structural configuration and placement of each functional group.

• Structure–Activity Insights: The furan group affects lipophilicity and binding kinetics, offering different interactions compared to MDMA’s methylenedioxy ring.

• 3D Modeling Capable: Its structure is suitable for 3D docking in receptor-ligand binding simulations, often used in computational chemistry labs.

Proper storage of 5-MAPB is essential to preserving its chemical integrity, ensuring consistent research outcomes, and maintaining its stability over time. Being moderately sensitive to environmental factors such as heat, light, and moisture, this compound should be kept in optimized laboratory conditions at all times.

• Cool, Dry Environment: Store 5-MAPB in a place that does not exceed 25°C (77°F). High temperatures can accelerate degradation and reduce efficacy.

• Away from Direct Sunlight: Exposure to UV light can cause photodegradation of the benzofuran structure, compromising the compound’s stability.

• Air-Tight Containers: Use sealable, moisture-resistant containers to prevent humidity intrusion. Vacuum-sealed or desiccant-packed jars are ideal.

• No Refrigeration Required (But Beneficial): While refrigeration is not mandatory, storing at 2–8°C can further extend its shelf life and prevent breakdown.

• Avoid Frequent Exposure: Minimize how often the container is opened. Repeated exposure to air and humidity can decrease potency over time.

• Clearly Labeled: Mark the container with the chemical name, date of receipt, and “For Research Use Only” label to prevent misuse.

• Segregate From Consumables: Store separately from any food, drink, or biological testing samples to avoid cross-contamination.

5-MAPB is not approved for in vivo studies involving humans or animals unless under highly controlled laboratory conditions with appropriate ethical clearances. As a research chemical, it has not undergone formal toxicological testing for safety in living organisms. Its use is strictly limited to in vitro assays, receptor binding studies, and simulated pharmacological models in line with chemical research ethics and national regulations.

• Not for Human Consumption: 5-MAPB is not a pharmaceutical or supplement. It lacks approval from agencies like the FDA or EMA and cannot be used in clinical or recreational contexts.

• Legal and Ethical Restrictions: In vivo research involving this compound must comply with institutional review boards (IRBs), animal ethics committees, or similar regulatory bodies where applicable.

• Unstudied Toxicological Profile: Long-term health effects, organ toxicity, and bioaccumulation patterns in humans or animals remain largely unknown, which poses significant risks.

• Dosage Risk: Without established therapeutic indices, any in vivo exposure carries unpredictability regarding safety margins, making such experiments ethically questionable outside authorized frameworks.

• Molecular Stability in Biological Systems: While 5-MAPB may demonstrate stability in solution, its metabolic breakdown in live systems could result in unknown by-products with unknown effects.

• Labelled for Research Only: RC Plug provides 5-MAPB with clear labeling and documentation specifying “Not for human consumption” and “For research use only.”

• Institutional Research Only: In rare cases where in vivo models are used (e.g., rodent brain studies), strict licenses and safety protocols must be in place to proceed.

While both 5-MAPB and MDMA are studied for their entactogenic properties, they exhibit notable differences in structure, duration, binding affinity, and safety profiles. These differences help researchers better understand the effects of molecular alterations on emotional, serotonergic, and stimulant responses.

• Structural Difference: MDMA is a phenethylamine with a methylenedioxy ring, while 5-MAPB is a benzofuran analog, introducing a different electronic structure and binding pattern.

• Effect Strength: MDMA produces more intense stimulant and euphoric effects, whereas 5-MAPB is reported in research to offer a milder, smoother empathogenic profile.

• Duration of Action: Both compounds have similar durations (4–6 hours), though 5-MAPB may exhibit a slightly slower onset and more stable plateau in simulation models.

• Receptor Binding: MDMA has broader action on SERT, DAT, and NET, while 5-MAPB is more selective toward serotonin transporters, possibly reducing dopaminergic overstimulation.

• Potential Neurotoxicity: 5-MAPB may show reduced oxidative stress and serotonin depletion in vitro, suggesting a lower neurotoxic profile than MDMA, though human data is lacking.

• Legal Classification: MDMA is widely scheduled and illegal in most countries, while 5-MAPB remains unscheduled or analogue-classified in many regions, offering a less restricted option for study.

• Research Use: Scientists often use 5-MAPB as a substitute for MDMA in receptor-affinity or entactogen-effect experiments where regulatory access to MDMA is blocked.

Yes. All batches of 5-MAPB supplied by RC Plug undergo stringent quality control to ensure their suitability for scientific research. Purity testing is a fundamental part of our process, ensuring each product meets the performance standards needed in analytical and behavioral laboratories.

• ≥98% Verified Purity: Our 5-MAPB consistently meets or exceeds this threshold, as confirmed by standard industry testing protocols.

• Gas Chromatography–Mass Spectrometry (GC-MS): This method is used to detect and quantify any trace-level contaminants or adulterants.

• High-Performance Liquid Chromatography (HPLC): HPLC results help confirm compound purity by separating and analyzing chemical constituents with high resolution.

• Visual Inspection: Each batch is manually reviewed for consistency in texture, color, and crystalline structure before final sealing.

• Documentation: Purity certificates or lab results are available on request to support institutional transparency and research validation.

• No Fillers or Binders: RC Plug guarantees that no inactive agents or additives are present in any chemical we distribute.

• Batch Control Numbers: Every package includes a traceable batch ID that corresponds to internal QC data and analytical verification.

As with any unapproved or novel research chemical, 5-MAPB presents various risks that must be acknowledged and managed. These risks are especially important when handling it in environments lacking adequate chemical hygiene or when researchers fail to follow ethical guidelines regarding its use.

• Limited Toxicological Data: The absence of comprehensive long-term safety studies means its full risk profile remains unknown.

• Possible Serotonin Overload: Despite its lower potency than MDMA, excessive exposure may still disrupt serotonin homeostasis in test systems, particularly at high concentrations.

• Unregulated Metabolites: The compound’s breakdown products have not been well-characterized and may pose unknown hazards during biological research.

• Cross-Contamination Risk: Improper handling could lead to unintentional contamination of other research materials, especially in multi-compound laboratories.

• Allergic or Irritant Reaction: Dust inhalation or dermal exposure could trigger minor skin, eye, or respiratory irritation in sensitive individuals, even if not systemically toxic.

• Misuse Potential: In regions with lax regulation, there is potential for unethical human testing or mislabeling, which could lead to legal or health consequences.

• Customs Seizures: Although not globally scheduled, importation of 5-MAPB may trigger customs scrutiny or legal penalties in regions with analogue laws.

RC Plug offers some of the fastest and most secure shipping services in the research chemical industry. Our fulfillment process is optimized to ensure that every 5-MAPB order is handled with precision, discretion, and urgency, regardless of destination.

• Same-Day Dispatch: Orders confirmed and paid before our daily cutoff (typically 4 PM local time) are processed and shipped the same day.

• Overnight U.S. Delivery: Customers in the United States can choose overnight express shipping for next-day delivery in most major cities.

• International Express: For global clients, we offer express options (3–5 business days) with major couriers to ensure minimal wait times.

• Real-Time Tracking: Every order comes with a tracking number, activated within hours of dispatch, enabling full visibility of your shipment.

• Tamper-Proof Packaging: All items are vacuum-sealed and packaged in plain, nondescript materials to prevent tampering and protect confidentiality.

• Discreet Customs Labeling: We use generic descriptions on all customs forms to reduce the likelihood of inspection or seizure.

• Shipping Guarantees: Should your shipment be lost or seized, we provide documentation assistance and may offer a replacement under our 30-day satisfaction guarantee.

Solubility is an essential factor in chemical research, especially when preparing solutions for spectroscopy, chromatography, or receptor-binding assays. 5-MAPB, like many benzofuran derivatives, shows selective solubility across various organic solvents but limited compatibility with aqueous mediums. Understanding which solvents work best for this compound helps ensure experimental accuracy and stability.

• Ethanol: One of the most commonly used solvents for 5-MAPB, ethanol provides a clean, efficient dissolution and is suitable for spectrophotometric applications and bioassay preparation.

• DMSO (Dimethyl Sulfoxide): Ideal for high-concentration solutions, DMSO enables stable storage and is compatible with both in vitro bioassays and certain analytical techniques.

• Methanol: A volatile yet effective solvent that works well for chromatographic applications, especially when high sensitivity is required in HPLC or LC-MS systems.

• Acetone: Although not a first-line solvent due to its rapid evaporation, acetone can dissolve 5-MAPB and is occasionally used for cleaning or extraction purposes.

• Limited Aqueous Solubility: 5-MAPB is largely insoluble in water due to its lipophilic benzofuran ring. Researchers typically avoid aqueous solutions unless using co-solvents or emulsifiers.

• Compatibility with Organic Phases: In biphasic systems or partition coefficient experiments, 5-MAPB favors organic layers, aiding in lipophilicity and pharmacokinetic simulations.

• Avoid Acidic or Basic Solvents: Strong acids or bases can degrade the compound, particularly targeting the amine group or furan ring, leading to decomposition or by-product formation.

For ethical and safety reasons, RC Plug does not provide synthesis instructions, nor do we encourage unauthorized chemical manufacturing. However, from a research perspective, understanding the theoretical chemical pathways of 5-MAPB is important for pharmacologists, analytical chemists, and forensic toxicologists analyzing related structures or derivatives.

• Theoretical Pathways Only: Most synthetic routes involve condensation of substituted benzofuran precursors with N-methylpropylamine intermediates, followed by reductive amination.

• Not for Amateur Synthesis: These procedures require precise temperature control, inert atmospheres, and regulated chemicals — unsuitable for non-professional environments.

• Used for SAR Exploration: Synthesis knowledge supports research into structural analogues, helping chemists modify or predict entactogenic behavior based on ring substitutions or side-chain modifications.

• Patent Literature References: Some synthesis details appear in outdated patent filings or pharmaceutical research documents, primarily for academic modeling, not practical use.

• Legal Regulation of Precursors: Many synthesis routes rely on precursor chemicals that are themselves controlled or monitored, making unauthorized synthesis both dangerous and illegal.

• Forensic Chemistry Applications: Knowledge of synthetic pathways allows forensic labs to identify synthesis routes from residue analysis in illicit samples seized by authorities.

• Importance in Purity Verification: A clear understanding of possible by-products or intermediates assists researchers in identifying impurities in substandard commercial 5-MAPB.

Although 5-MAPB is not studied clinically, pharmacodynamic simulations and in vitro models provide a general sense of its temporal activity. These findings are valuable in predicting receptor saturation, downregulation potential, and the overall time-course for behavioral pharmacology assays.

• 4–6 Hour Active Phase: Based on comparison with similar compounds, 5-MAPB’s core activity spans roughly four to six hours, with a slow onset and steady plateau.

• Mild Build-Up: Unlike MDMA’s fast-onset, 5-MAPB takes longer to reach full receptor occupancy in simulated binding models, indicating a delayed but smoother experience.

• Slower Reuptake Inhibition Curve: In vitro tests show prolonged serotonin transporter inhibition, suggesting sustained neurotransmitter modulation over several hours.

• Moderate Metabolic Breakdown: Research suggests that metabolic degradation is gradual, with intermediate compounds persisting for extended periods post-administration in simulation models.

• Post-Activity Residual Effects: While the primary action fades after 6 hours, indirect effects such as receptor downregulation or serotonergic aftereffects can linger in biological systems for longer.

• Duration Affects Research Design: For receptor-binding studies, dose intervals and timing must account for its extended plateau to avoid overlap or misinterpretation of data.

Yes, preliminary metabolic modeling and limited in vitro studies indicate that 5-MAPB undergoes several metabolic transformations when processed by liver microsomes or simulated enzymatic systems. These metabolites are important for toxicology, forensic testing, and receptor-binding modeling.

• N-Demethylation: Removal of the N-methyl group is a common phase I metabolic step, yielding a primary amine that may have altered receptor activity or toxicity.

• Ring Hydroxylation: Hydroxylation at the benzofuran ring increases polarity, making the compound more water-soluble and facilitating renal clearance.

• Deamination: The removal of the amino group results in the formation of aldehyde intermediates, which may bind to proteins or DNA under certain lab conditions.

• Phase II Conjugation: Glucuronidation and sulfation are likely to occur following hydroxylation, creating easily excretable metabolites that appear in bioassay screens.

• Inactive By-Products: Some metabolites appear to be pharmacologically inactive, suggesting rapid detoxification by the body in in vivo simulation studies.

• Comparison with 6-APB and MDMA Metabolites: Researchers often compare 5-MAPB’s metabolic breakdown to similar structures to evaluate safety and predict residue detection timelines.

• Detectable by LC-MS/MS: Advanced toxicological equipment can identify both the parent compound and its metabolites, allowing forensic tracking and pharmacokinetic modeling.

Standard workplace drug tests and consumer-level screening kits do not typically detect 5-MAPB, unless they are specifically designed to identify novel psychoactive substances (NPS). However, certain advanced testing methodologies are capable of detecting both the parent molecule and its metabolites, particularly in forensic or post-mortem contexts.

• Not Detected in Routine Panels: Standard 5-panel or 10-panel urine drug tests do not include 5-MAPB or its analogs unless tailored for designer drugs.

• False Positives Possible: Some testing equipment may confuse 5-MAPB with MDMA or MDA metabolites due to structural similarities, but this is uncommon.

• Detectable with LC-MS/MS: High-resolution liquid chromatography with mass spectrometry can identify 5-MAPB with high precision in plasma, urine, or serum samples.

• Parent vs. Metabolite Detection: Many labs focus on identifying 5-MAPB’s specific metabolites rather than the compound itself, especially when studying delayed excretion patterns.

• Forensic Panel Inclusion: In regions where NPS abuse is a concern, 5-MAPB may be included in extended toxicology panels used by law enforcement or hospitals.

• Not Part of Employment Screens: As of now, there is no widespread corporate or DOT inclusion of 5-MAPB in occupational drug testing guidelines.

• Research Labs May Develop Standards: Analytical laboratories often synthesize their own reference standards to test for newly emerging compounds like 5-MAPB.

Neurotoxicity is a critical consideration in the study of serotonergic compounds. While definitive clinical data on 5-MAPB is unavailable, in vitro and comparative research suggest that it may carry a reduced neurotoxic risk compared to MDMA, though this has not been confirmed in longitudinal or in vivo models. The compound’s structure indicates possible differences in oxidative stress and neurotransmitter depletion mechanisms, but researchers must approach all testing with caution due to the limited data.

• Lower Oxidative Stress Indicators: Laboratory simulations suggest 5-MAPB produces fewer reactive oxygen species (ROS) than MDMA when interacting with neuronal models.

• Minimal Serotonin Depletion (In Vitro): Tests involving SERT-expressing cells show less serotonin transporter downregulation after exposure to 5-MAPB, implying reduced neurotoxicity.

• Lack of Long-Term Data: There are currently no validated longitudinal studies examining 5-MAPB’s effect on serotonin pathways or brain health over extended periods.

• Mitochondrial Activity: Some early research points to more stable mitochondrial function in neuron-like cells exposed to 5-MAPB compared to MDMA.

• Still Experimental: Despite promising indicators, the compound is far from being proven “neuro-safe” and must be handled under strict lab protocols.

• Concentration-Specific Effects: Toxicity appears dose-dependent in most simulations, with higher concentrations increasing the likelihood of cell stress and receptor dysfunction.